TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

192.90$ +0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Revolution Medicines Inc (RVMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RVMD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.7 0.0 0.0 0.0 262 0.0 0.0 0.0 0.0 0.0 0.0 0.0
108 137 118 13 152 188 206 3.8 4.7 4.5
-108 0.7 -118 -13 -152 -188 -206 -3.8 -4.7 -4.5
108 148 118 135 152 188 206 224 263 293 344 395 1,294
16 32 23 22 24 28 35 41 53 64 101 110 329
123 181 141 157 176 216 241 265 315 357 441 505 1,618
-123 -180 -141 -157 -176 -216 -241 -265 -315 -362 -445 -505 -1,627
9.3 0.9 11 12 12 24 59
-112 -161 -116 -133 -156 -195 -213 -248 -305 -365 -454 -644 -1,768
-3.9 0.3 -2.8 -156 -0.8
-108 -162 -116 -133 -156 -195 -213 -248 -305 -365 -454 -644 -1,768
-110 -130 -113 -130 -153 -192 -210 -244 -289 -348 -437 -621 -1,695

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?